Skip to content

Meet us at COP31Read more

Dextech Medical AB Sustainability Reports

Dextech Medical AB is a Swedish biopharmaceutical research company specializing in urological oncology, primarily focused on developing drug candidates for prostate cancer. Its development portfolio includes carbohydrate-based molecules coupled with active substances to satisfy major unmet needs in clinical oncology.

Sector: Professional & technical services

Country: Sweden

Exchange: Nordic Growth Market

LEI: 549300O3OL7X6EWKLO53

FIGI: BBG006FYYD09

21 reports from 2011 to 2026